MEDINICE

Research MEDINICE (ICE.WA) on Bullrun: market cap PLN 572.06M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is PLN 572.06M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025PLN 0-PLN 6.72M-PLN 11.65Mn/an/aPLN 9.60MPLN 365.00KPLN 88.12M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-09-05PLN 572.06Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 PLN.

About MEDINICE

Medinice S.A., a medical technology company, creates, develops, and commercializes minimally invasive solutions in cardiology and cardiac surgery. The company offers PacePress, a medical device to reduce the risk of complications following the implantation of cardiac electrotherapeutic devices, such as pacemakers or implantable cardioverter-defibrillators; CoolCryo, a cardiac cryoablation technology that uses liquid nitrogen as the cooling medium;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is MEDINICE's market cap?

MEDINICE's market capitalization is PLN 572.06M.

What does MEDINICE do?

Medinice S.A., a medical technology company, creates, develops, and commercializes minimally invasive solutions in cardiology and cardiac surgery. The company offers PacePress, a medical device to reduce the risk of complications following the implantation of cardiac electrotherapeutic devices, such as pacemakers or implantable cardioverter-defibrillators; CoolCryo, a cardiac cryoablation technology that uses liquid nitrogen as the cooling medium; and AtriClamp, a clip designed to close the left atrial appendage to minimize the risk of stroke in patients with atrial fibrillation.